Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; Reported that they inadvertently administered 51 doses of the monovalent vaccines; 1st dose on 02-Sep-2021 and 2nd dose on 23-Sep-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Reported that they inadvertently administered 51 doses of the monovalent vaccines), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 02-Sep-2021 and 2nd dose on 23-Sep-2021) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, FF8839 and EW0186) for COVID-19 prophylaxis.     It was unknown if the patient was ever been diagnosed with or tested positive for COVID-19. Acute illnesses at the time of vaccination and up to one month before was unknown. Chronic or long-standing health conditions were unknown. Prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination and all at the time of adverse event was unknown.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 02-Sep-2021 and 2nd dose on 23-Sep-2021). On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Reported that they inadvertently administered 51 doses of the monovalent vaccines). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Reported that they inadvertently administered 51 doses of the monovalent vaccines), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 02-Sep-2021 and 2nd dose on 23-Sep-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Reported that they inadvertently administered 51 doses of the monovalent vaccines) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 02-Sep-2021 and 2nd dose on 23-Sep-2021).    No concomitant product reported by reporter.  No treatment medication was reported.  Dose/ volume for 3rd booster dose was reported as 0.25.   This case was linked to MODERNATX, INC.-MOD-2023-704260 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2023: Follow-up received: Suspect route of administration, site of administration was updated, and additional event was added. Sender's Comments:  MODERNATX, INC.-MOD-2023-704260: Master case